TSXV/WAVE (TSXV/WAVE)

TSX Venture Exchange: TSXV/WAVE · CAD

CA$0.01

+0.00 (0.0%)· Recorded snapshot

Market cap	540K
Revenue (ttm)	1.2M
Net income (ttm)	-744.4K
EPS (ttm)	-CA$0.02
Shares out	54M
Volume	0
Beta	1.46

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 1.2M
Net income (ttm): -744.4K
EPS (ttm): -CA$0.02
Market cap: 540K

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/En/a

P25 11P50 16.8P75 23.9

Trailing P/En/a

P25 9.9P50 23.3P75 38.5

ROEn/a

P25 -104.1P50 -30P75 6.7

ROIC-39.7

P25 -55.9P50 -12.1P75 5

Benchmarks · 1M

All TSXV/WAVE indicators

Market & fundamental data

Available fields

145

Groups with data

Currency

CAD

Showing 145 of 145 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CAD
Country	Canada
Country code	CA
Earnings date	2026-11-27
Enterprise value	CAD 4.1M
Exchange	TSX Venture Exchange
Financial currency	CAD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	2014
Industry	Biotechnology
Is primary listing	Yes
ISIN number	CA94357L1058
Last earnings date	2025-11-27
Last refreshed	2026-10-29
Market cap	CAD 540,000
Next earnings date	2026-11-27
Price	CAD 0.01
Price currency	CAD
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-09
Symbol	tsxv/WAVE
Website	https://www.waverleypharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-180.61%
EV/Sales	3.49x
FCF / EV yield	-12.89%
FCF yield	-97.85%
P/S ratio	0.46x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-47.75%
EBITDA margin	-42.9%
Gross margin	33.48%
Operating margin	-47.75%
Pretax margin	-63.26%
Profit margin	-63.4%
ROA	-28.13%
ROA (5Y)	-25.07%
ROCE	20.85%
ROIC	-39.75%
Tax / revenue	0.14%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Gross profit growth	-27.24%
Gross profit growth (Q)	-39.08%
Gross profit growth 3Y	14.03%
Gross profit growth 5Y	2.24%
Revenue growth	-6.23%
Revenue growth (Q)	-18.45%
Revenue growth (QoQ)	9.52%
Revenue growth 3Y	14.2%
Revenue growth 5Y	-6.94%

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Depreciation and amortization	CAD 56,928
EBIT	CAD -560,666
EBITDA	CAD -503,738
EPS	CAD -0.02
FCF per share	CAD -0.01
Financing cash flow	CAD 426,776
Free cash flow	CAD -528,370
Gross profit	CAD 393,101
Income taxes	CAD 1,631
Net borrowing	CAD 426,776
Net cash flow	CAD -102,185
Net income	CAD -744,438
Operating income	CAD -560,666
Revenue	CAD 1.2M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-18.3
Book value per share	CAD -0.05
Goodwill	CAD 220,779
Interest coverage	-3.03
Long-term assets	CAD 756,974
Long-term liabilities	CAD 170,505
Net cash (debt)	CAD -3.6M
Net cash / market cap	-659.14%
Piotroski F-Score	1
Property, plant and equipment	CAD 216,379
Shareholders' equity	CAD -2.9M
Tangible book value	CAD -3.4M
Tangible book value per share	CAD -0.06
Total assets	CAD 1.1M
Total cash	CAD 45,048
Total debt	CAD 3.6M
Total liabilities	CAD 4M
WACC	5.12%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.94
Current assets	CAD 349,026
Current liabilities	CAD 3.8M
Current ratio	0.09
Inventory turnover	3.05
Net working capital	CAD -56,584
Quick ratio	0.02
Working capital	CAD -3.4M
Working capital turnover	-0.37

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	CAD 0.02
1D price change	0%
1M price change	-33.33%
1M total return	-33.33%
1Y price change	-50%
1Y return CAGR	-50.02%
1Y total return	-50%
20-day SMA	CAD 0.01
200-day SMA	CAD 0.02
3M price change	-60%
3M total return	-60%
3Y price change	-71.43%
3Y return CAGR	-34.13%
3Y total return	-71.43%
50-day SMA	CAD 0.02
50-day SMA vs 200-day SMA	50under200
52-week high	CAD 0.04
52-week high date	2026-02-06
52-week low	CAD 0.01
52-week low date	2026-10-09
5Y price change	-90.48%
5Y return CAGR	-37.52%
5Y total return	-90.48%
All-time high	CAD 0.60
All-time high date	2017-10-30
All-time low	CAD 0.01
All-time low date	2024-08-23
Average true range (ATR)	CAD 0.00
Average volume	11.5K
Beta (1Y)	0.09
Beta (2Y)	0.66
Beta (5Y)	1.46
Change from 52-week high	-75%
Change from 52-week low	0%
Change from all-time high	-98.33%
Change from all-time low	0%
Monthly RSI	44.31
Previous close	CAD 0.01
Price vs 150-day SMA	-44.44%
Price vs 20-day SMA	-30.07%
Price vs 200-day SMA	-54.13%
Price vs 50-day SMA	-43.82%
Relative volume	0.17
RSI	43.36
Sharpe ratio	1.63
Sortino ratio	3.02
Volume	0
Weekly RSI	42.03
YTD price change	-50%
YTD total return	-50%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	13.6M
Shares change (QoQ)	0%
Shares held by insiders	74.9%
Shares outstanding	54M

Deeper analysis on TSXV/WAVE

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this TSXV/WAVE report

Is a complete TSXV/WAVE research report available?

No complete published report is available for tsxv/WAVE (TSXV/WAVE) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

TSXV/WAVE (TSXV/WAVE)

Price

Financial snapshot

Fair-value bridge

Latest news · TSXV/WAVE

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All TSXV/WAVE indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Performance and technicals

Ownership and float

Deeper analysis on TSXV/WAVE

Frequently asked questions